Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

About this update from Iridex Corporation

[{"type":"image","alt":"IRIDEX Corporation","displaySize":"","headline":null,"caption":"IRIDEX Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":90,"url":"https://media.zenfs.com/en/globenewswire.com/ffe273cdb8e913085b9d4a020e219250"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/r51WXqBBd3BbgLab_DBobg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ffe273cdb8e913085b9d4a020e219250","width":300,"height":90}},"lazy":false},{"type":"text","content":"MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the fourth quarter and full year ended December 28, 2024.","length":371,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2024 Results & Recent Highlights","length":51,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Achieved positive adjusted EBITDA in the fourth quarter of 2024","length":63,"tagName":"p"}]},{"val":[{"type":"text","content":"Successfully implemented previously announced cost reduction program, resulting in operating expenses of $6.1 million, a 24% reduction compared to $8.0 million in the prior year period","length":184,"tagName":"p"}]},{"val":[{"type":"text","content":"Generated total revenue of $12.7 million, compared to $12.5 million in the prior year quarter","length":108,"tagName":"p"}]},{"val":[{"type":"text","content":"Cyclo G6® product family revenue in the fourth quarter reached $3.3 million, compared to $3.0 million in the prior year quarter","length":137,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Sold 13,300 Cyclo G6® probes, compared to 12,700 in the prior year quarter","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Sold 47 Cyclo G6® Glaucoma Laser Systems in the fourth quarter of 2024, compared to 35 in the prior year quarter","length":112,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":186,"olType":false}]},{"val":[{"type":"text","content":"Retina product revenue was $7.3 million, compared to $7.5 million in the prior year quarter","length":1...

More updates from Iridex Corporation